BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

9 Months Ended

Sep. 30, 2016

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and nine months ended September 30, 2016 and 2015 are as follows:

	Three Months Ended								Nine Months Ended
	September 30,								September 30,
	2016				2015				2016				2015
Laser systems		71.9	%			65.3	%			68.7	%			65.2	%
Imaging systems		2.6	%			6.4	%			4.5	%			4.7	%
Consumables and other		12.4	%			13.1	%			13.5	%			15.5	%
Services		12.9	%			14.9	%			13.0	%			14.1	%
License fees and royalties		0.2	%			0.3	%			0.3	%			0.5	%
Total revenue		100.0	%			100.0	%			100.0	%			100.0	%